Skip to content

Peptides / Epitalon

Panel: recommendedPineal peptideNot FDA approved

Epitalon

Epitalon, also spelled epithalon, is a four-amino-acid synthetic peptide modelled on an extract of the pineal gland, the small gland in the brain that makes the sleep hormone melatonin. It was developed in St Petersburg, Russia.

Reviewed for
Insomnia
Committee vote
7 yes, 4 or 5 no
Strongest evidence
Small human studies
Legal to compound in the US
Not yet

Effects studied or claimed

What it is promoted for, and where each effect has actually been seen

  • Better sleep and a normal melatonin rhythmClaimed
  • Slower ageing of cells, including longer telomeresLab studies
  • Longer lifespanSome animal studies

How it is thought to work

It is said to regulate melatonin production and to switch on telomerase, an enzyme that maintains telomeres, the protective caps on chromosomes. Neither has been proven in people.

What the evidence shows

In animals and the lab

Lifespan and tumour studies in rodents and fruit flies, mostly from the same research group.

In people

A small number of studies in older people, almost all from that same Russian group, with no independent confirmation.

Safety and unknowns

Unknown. Switching on telomerase is itself a theoretical cancer concern, because many cancers depend on it to keep dividing.

FDA review

Reviewed for insomnia. FDA staff recommended against it. The committee voted 7 in favour, with 4 or 5 against depending on the report.

Committee votes are advice to the FDA. A peptide can only be compounded legally once the FDA adds it to the 503A bulks list through formal rulemaking, which has no fixed deadline.

Analysis

The telomere claim, and where it comes from

Peptide Evidence IndexBiology 3/10In people 1.5/10Index 1.9, rank 13 of 15See the full index

Epitalon is a four-amino-acid peptide created by Vladimir Khavinson in St Petersburg as a synthetic copy of a pineal gland extract called epithalamin. It is marketed as an anti-ageing peptide that lengthens telomeres, the protective caps on chromosomes that shorten as cells divide.

That claim traces to a 2003 study in which Epitalon switched on the telomerase enzyme and lengthened telomeres in human cells grown in a dish (Khavinson and colleagues). The same institute reported that mice given Epitalon lived longer and developed fewer tumours (Anisimov and colleagues, 2003). The most striking human report concerns the parent extract: in older people followed for six to eight years, those given pineal and thymus peptide extracts had lower death rates than controls (Khavinson and Morozov, 2003).

Our view. the findings are intriguing but come almost entirely from one research network, have rarely been replicated independently, and the human data predate modern trial standards. Lengthening telomeres is also not automatically good, since cancer cells rely on telomerase.

Studies and reports cited

  1. Khavinson VK et al. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med, 2003
  2. Anisimov VN et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology, 2003
  3. Khavinson VK, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett, 2003

Summary of published research for general information. It is not medical advice and not a recommendation to use this substance.

General information, not medical advice. Do not buy or inject unregulated peptides.